Browsing Tag
Natural Capsules Limited
2 posts
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Natural Capsules Limited’s Q3 FY26 results reveal regulatory recovery, tariff relief, and lingering API risks. Find out what this means for investors next.
Is the worst behind for Natural Capsules (NSE: NATCAPSUQ) after API delays and US tariff headwinds?
Natural Capsules reports Q2FY26 loss amid US tariff pressure and API delays. Find out if its PLI benefits and expansion plans can turn the tide.